https://consumer.healthday.com/bedaquiline-pretomanid-linezolid-regimens-compared-for-xdr-tb-2657965270.html
0
0
9/16/22 at 4:08pm
Organization
Healthday.com
Author
Physician’s Briefing Staff
28 words
0
Comments
Overall risk-benefit ratio seems to favor patients receiving linezolid at dose of 600 mg for 26 weeks
You are the first to view
Create an account
or login to join the discussion